Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
BackgroundKi67 is a biomarker of proliferation to be used in immunohistochemistry (IHC)-based surrogate assay to determine the necessity of cytotoxic therapy for Luminal-like breast cancer patients. cyclinD1 is another frequently used biomarker of proliferation. A retrospective study was performed h...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/7d3287aa92df48ea9ea56251068666fa |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|